These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 3222783

  • 1. Immunovisualization of fibrinogen A alpha-chain heterogeneity in normal plasma and plasma from patients with DIC or on streptokinase therapy.
    Grøn B, Bennick A, Nieuwenhuizen W, Bjørnsen S, Brosstad F.
    Thromb Res; 1988 Dec 01; 52(5):413-24. PubMed ID: 3222783
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Purification and characterization of 3 fibrinogens with different molecular weights obtained from normal human plasma.
    Holm B, Nilsen DW, Kierulf P, Godal HC.
    Thromb Res; 1985 Jan 01; 37(1):165-76. PubMed ID: 3983897
    [Abstract] [Full Text] [Related]

  • 4. Normal and fibrinaemic patient plasma contain high-molecular weight crosslinked fibrin(ogen) derivatives with intact fibrinopeptide A.
    Grøn B, Bennick A, Nieuwenhuizen W, Brosstad F.
    Thromb Res; 1990 Jan 15; 57(2):259-70. PubMed ID: 2315888
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Characterization of fibrinogen/fibrin derivatives isolated from normal and fibrinaemic plasma and serum using paramagnetic particles coated with a monoclonal antibody (mAb) to D-dimer.
    Grøn B, Bennick A, Filion-Myklebust C, Brosstad F.
    Blood Coagul Fibrinolysis; 1993 Jun 15; 4(3):447-54. PubMed ID: 8329572
    [Abstract] [Full Text] [Related]

  • 8. A quantitative enzyme immunoassay for primary fibrinogenolysis products in plasma.
    Koppert PW, Kuipers W, Hoegee-de Nobel B, Brommer EJ, Koopman J, Nieuwenhuizen W.
    Thromb Haemost; 1987 Feb 03; 57(1):25-8. PubMed ID: 2438796
    [Abstract] [Full Text] [Related]

  • 9. Fibrinogen heterogeneity in homozygous plasminogen deficiency type I: further evidence that plasmin is not involved in formation of LMW- and LMW'-fibrinogen.
    Dempfle CE, Pfitzner SA, Schott D, Niessen KH, Heene DL.
    Thromb Haemost; 1997 May 03; 77(5):879-83. PubMed ID: 9184396
    [Abstract] [Full Text] [Related]

  • 10. Differential effects of activation of prothrombin by streptokinase compared with urokinase and tissue-type plasminogen activator (t-PA).
    Eisenberg PR, Miletich JP, Sobel BE, Jaffe AS.
    Thromb Res; 1988 Jun 01; 50(5):707-17. PubMed ID: 3137687
    [Abstract] [Full Text] [Related]

  • 11. Isolation of fibrinogen A alpha-chain by affinity chromatography on concanavalin A-sepharose.
    Bögli C, Hofer A, Furlan M.
    Thromb Haemost; 1988 Oct 31; 60(2):308-10. PubMed ID: 3217923
    [Abstract] [Full Text] [Related]

  • 12. The development of assays for the detection of fibrin(ogen)olysis based on COOH-terminal A alpha chain epitopes.
    Sobel JH, Wu HQ, Canfield RE.
    Blood; 1994 Jul 15; 84(2):535-46. PubMed ID: 7517717
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Studies on the functionality of newly synthesized fibrinogen after treatment of acute myocardial infarction with streptokinase, increase in the rate of fibrinopeptide release.
    Reganon E, Vila V, Aznar J, Lacueva V, Martinez V, Ruano M.
    Thromb Haemost; 1993 Dec 20; 70(6):978-83. PubMed ID: 8165621
    [Abstract] [Full Text] [Related]

  • 17. Fibrinopeptide A and the phosphate content of fibrinogen in venous thromboembolism and disseminated intravascular coagulation.
    Leeksma OC, Meijer-Huizinga F, Stoepman-van Dalen EA, van Ginkel CJ, van Aken WG, van Mourik JA.
    Blood; 1986 May 20; 67(5):1460-7. PubMed ID: 3697510
    [Abstract] [Full Text] [Related]

  • 18. Fibrinogen and its derivatives, hereditary and acquired abnormalities.
    Marder VJ, Buszynski AZ.
    Schweiz Med Wochenschr; 1974 Sep 28; 104(39):1338-42. PubMed ID: 4421373
    [No Abstract] [Full Text] [Related]

  • 19. Plasmic degradation of fibrinogen Paris I.
    Budzynski AZ, Marder VJ.
    J Lab Clin Med; 1976 Nov 28; 88(5):817-25. PubMed ID: 978044
    [Abstract] [Full Text] [Related]

  • 20. Fibrinopeptide A in plasma of normal subjects and patients with disseminated intravascular coagulation and systemic lupus erythematosus.
    Cronlund M, Hardin J, Burton J, Lee L, Haber E, Bloch KJ.
    J Clin Invest; 1976 Jul 28; 58(1):142-51. PubMed ID: 932202
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.